Twin Tree Management LP purchased a new position in Stevanato Group S.p.A. (NYSE:STVN – Free Report) during the 1st quarter, Holdings Channel reports. The institutional investor purchased 1,425 shares of the company’s stock, valued at approximately $29,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Whittier Trust Co. purchased a new stake in shares of Stevanato Group during the first quarter valued at $27,000. SVB Wealth LLC purchased a new stake in shares of Stevanato Group during the first quarter valued at $46,000. Van Berkom & Associates Inc. grew its holdings in shares of Stevanato Group by 33.3% during the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock valued at $49,000 after buying an additional 600 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Stevanato Group by 680.3% during the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock valued at $71,000 after buying an additional 2,830 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock valued at $162,000 after buying an additional 4,965 shares during the last quarter.
Stevanato Group Price Performance
NYSE:STVN opened at €23.14 on Tuesday. Stevanato Group S.p.A. has a one year low of €17.12 and a one year high of €28.00. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79. The firm has a market cap of $7.01 billion, a price-to-earnings ratio of 42.85, a PEG ratio of 2.17 and a beta of 0.55. The firm’s fifty day moving average is €24.21 and its two-hundred day moving average is €22.55.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on Stevanato Group
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
- Five stocks we like better than Stevanato Group
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Healthcare Pathbreakers With Long-Term Tailwinds
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Tariff-Proof Retailers Making New All-time Highs
- What is MarketRank™? How to Use it
- With Shares Near Highs, Here’s to Watch in Broadcom’s Q3 Report
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.